Health Canada regulates Alli’s sale as a non-prescription weight-loss aid. This means they oversee its safety and efficacy before approval and monitor its use afterward.
Manufacturers must submit comprehensive data demonstrating Alli’s safety and effectiveness to Health Canada for review. This includes clinical trial results and manufacturing information.
Health Canada actively monitors adverse events reported by consumers. They investigate complaints thoroughly and may take action if necessary, including product recalls or label changes.
Alli’s labeling must clearly state potential side effects, usage instructions, and contraindications. Health Canada ensures this information is accurate and readily understandable to consumers.
Regular inspections of manufacturing facilities occur to verify compliance with Canadian regulations and quality standards for Alli production.
Consumers can report adverse events or product issues directly to Health Canada. This information directly supports ongoing product safety surveillance.
Health Canada’s website provides detailed information on Alli, including safety warnings and FAQs. Consumers should consult this resource before use.
